Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs iShares Global Tech ETF (IXN) Price & Performance

HCA Health IncTrade
iShares Global Tech ETFTrade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs iShares Global Tech ETF — how do they compare? HCA Health Inc trades at $446.07 (market cap $96.35B), while iShares Global Tech ETF trades at $149.51 (market cap $10.03B). The key difference: HCA Health Inc is far larger — about 9.6× iShares Global Tech ETF's market cap, and HCA Health Inc pays a 0.7% dividend while iShares Global Tech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and iShares Global Tech ETF for 46 Days on average.

HCAIXN
Market Cap
$96.35B$10.03B
Volume
1,079,453286,617
Sector
HealthSector/Thematic
52-Week High
$545.13$152.94
52-Week Low
$361.32$95.76
Typical Hold Time
76 Days46 Days
Enterprise Value
$146.88B—
Dividend Yield
0.7%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.

The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.

iShares Global Tech ETF

IXN trades at $152.16, down 0.51% today but near its 52-week high of $151.40, reflecting strong momentum. Technical indicators show a bullish moving average signal but overbought RSI levels. Recent news highlights the ETF's 34% gain and multiple compression, with a high-teens P/E ratio and 28.5% long-term EPS growth rate, emphasizing global tech exposure beyond the U.S.

The outlook remains positive due to AI exposure and global diversification, but risks include portfolio concentration and overbought conditions. Analyst sentiment is bullish, with buy ratings citing valuation appeal, though investors should monitor tech sector volatility and competitive pressures from international firms.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HCA
100% Buy0% Sell
Avg holding period · 76 Days
IXN
37% Buy63% Sell
Avg holding period · 46 Days

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →

About iShares Global Tech ETF

IXN provides exposure to global electronics, software, and hardware companies. It tracks the S&P Global 1200 Information Technology Index, covering tech leaders across both developed and emerging markets.

Read more on IXN →